These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17543526)

  • 21. Cytotoxicity of tiazofurin and its arabinose and xylose analogues in K562 cells.
    Zhen W; Jayaram HN; Marquez VE; Goldstein BM; Cooney DA; Weber G
    Biochem Biophys Res Commun; 1991 Oct; 180(2):933-8. PubMed ID: 1683233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The chemistry of nicotinamide adenine dinucleotide (NAD) analogues containing C-nucleosides related to nicotinamide riboside.
    Pankiewicz KW; Watanabe KA; Lesiak-Watanabe K; Goldstein BM; Jayaram HN
    Curr Med Chem; 2002 Apr; 9(7):733-41. PubMed ID: 11966436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition by tiazofurin of inosine 5'-phosphate dehydrogenase (IMP DH) activity in extracts of ovarian carcinomas.
    Look KY; Sutton GP; Natsumeda Y; Eble JN; Stehman FB; Ehrlich CE; Olah E; Prajda N; Bosze P; Eckhardt S
    Gynecol Oncol; 1992 Oct; 47(1):66-70. PubMed ID: 1358769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carboxamide group conformation in the nicotinamide and thiazole-4-carboxamide rings: implications for enzyme binding.
    Li H; Goldstein BM
    J Med Chem; 1992 Sep; 35(19):3560-7. PubMed ID: 1357174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IMP dehydrogenase: inhibition by the anti-leukemic drug, tiazofurin.
    Yamada Y; Natsumeda Y; Yamaji Y; Jayaram HN; Tricot GJ; Hoffman R; Weber G
    Leuk Res; 1989; 13(2):179-84. PubMed ID: 2564451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dehydrogenase binding by tiazofurin anabolites.
    Goldstein BM; Bell JE; Marquez VE
    J Med Chem; 1990 Apr; 33(4):1123-7. PubMed ID: 1969483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tiazofurine ICN Pharmaceuticals.
    Grifantini M
    Curr Opin Investig Drugs; 2000 Oct; 1(2):257-62. PubMed ID: 11249583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and biological activity of some new 5'-O-acyl tiazofurin derivatives.
    Pejanović V; Piperski V; Ugljesić-Kilibarda D; Tasić J; Dacević M; Medić-Mijacević L; Gunić E; Popsavin M; Popsavin V
    Eur J Med Chem; 2006 Apr; 41(4):503-12. PubMed ID: 16519966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new synthetic methodology for tiazofurin.
    Ramasamy KS; Bandaru R; Averett D
    J Org Chem; 2000 Sep; 65(18):5849-51. PubMed ID: 10970336
    [No Abstract]   [Full Text] [Related]  

  • 30. Cytotoxicity of a new IMP dehydrogenase inhibitor, benzamide riboside, to human myelogenous leukemia K562 cells.
    Jayaram HN; Gharehbaghi K; Jayaram NH; Rieser J; Krohn K; Paull KD
    Biochem Biophys Res Commun; 1992 Aug; 186(3):1600-6. PubMed ID: 1354960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell cycle dependent regulation of IMP dehydrogenase activity and effect of tiazofurin.
    Szekeres T; Fritzer M; Pillwein K; Felzmann T; Chiba P
    Life Sci; 1992; 51(16):1309-15. PubMed ID: 1357518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Synthesis, conformation analysis, and antiviral activity of benzimidazole ribofuranosides].
    Iavorskiĭ AE; Turov AV; Reshot'ko LN; Florent'ev VL
    Bioorg Khim; 1990 Jul; 16(7):963-8. PubMed ID: 2173605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On the conformation of tiazofurin analogues.
    Makara GM; Keserû GM
    J Med Chem; 1997 Dec; 40(25):4154-9. PubMed ID: 9406604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of cancer pathways by inhibitors of guanylate metabolism.
    Oláh E; Kökény S; Papp J; Bozsik A; Keszei M
    Adv Enzyme Regul; 2006; 46():176-90. PubMed ID: 16857242
    [No Abstract]   [Full Text] [Related]  

  • 35. Ara-tiazofurin: conservation of structural features in an unusual thiazole nucleoside.
    Goldstein BM; Mao DT; Marquez VE
    J Med Chem; 1988 May; 31(5):1026-31. PubMed ID: 3361573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis and antiproliferative activity of two new heteroannelated (-)-muricatacin mimics.
    Popsavin V; Srećo B; Benedeković G; Popsavin M; Francuz J; Kojić V; Bogdanović G
    Bioorg Med Chem Lett; 2008 Oct; 18(19):5182-5. PubMed ID: 18790637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and antitumor activity of 2-beta-D-ribofuranosyloxazole-4-carboxamide (oxazofurin).
    Franchetti P; Cristalli G; Grifantini M; Cappellacci L; Vittori S; Nocentini G
    J Med Chem; 1990 Oct; 33(10):2849-52. PubMed ID: 2120442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, conformational analysis, and biological activity of new analogues of thiazole-4-carboxamide adenine dinucleotide (TAD) as IMP dehydrogenase inhibitors.
    Franchetti P; Cappellacci L; Pasqualini M; Petrelli R; Jayaprakasan V; Jayaram HN; Boyd DB; Jain MD; Grifantini M
    Bioorg Med Chem; 2005 Mar; 13(6):2045-53. PubMed ID: 15727858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The kinetics of tiazofurin uptake by the isolated perfused choroid plexus of the sheep.
    Redzic ZB; Segal MB; Gasic JM; Markovic ID; Isakovic A; Rakic LM
    Methods Find Exp Clin Pharmacol; 2000 Apr; 22(3):149-54. PubMed ID: 10893696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and synthesis of trans 2-(furan-2-yl)vinyl heteroaromatic iodides with antitumour activity.
    Fortuna CG; Barresi V; Berellini G; Musumarra G
    Bioorg Med Chem; 2008 Apr; 16(7):4150-9. PubMed ID: 18248996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.